Stock Analiz

Phibro Animal Health Corp. (PAHC) financials: revenue, earnings and cash flow

Fiscal 2017–2026 + TTM · from SEC filings · data as of November 13, 2026

Summary

Phibro Animal Health’s revenue went from $764M in fiscal 2017 to $1.5B in fiscal 2026, growth of about 7.9% a year.

Net income in fiscal 2026 was $100M, a net margin of 6.6%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $1.5B and net income $103M.

Free cash flow was $10M in fiscal 2026 and positive in 8 of the 10 years shown.

The diluted share count rose 2% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2017: $764M172018: $820M182019: $828M192020: $800M202021: $833M212022: $942M222023: $978M232024: $1.0B242025: $1.3B252026: $1.5B26$1.5B
Net income
2017: $65M172018: $65M182019: $55M192020: $34M202021: $54M212022: $49M222023: $33M232024: $2M242025: $48M252026: $100M26$100M
Free cash flow
2017: $78M172018: $51M182019: $17M192020: $25M202021: $19M212022: -$5M222023: -$38M232024: $46M242025: $42M252026: $10M26$10M
EPS (diluted)
2017: $0.00172018: $0.00182019: $0.00192020: $0.83202021: $1.34212022: $1.21222023: $0.81232024: $0.06242025: $1.19252026: $2.4326$2.43

Income statement

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$1.5B$1.5B$1.3B$1.0B$978M$942M$833M$800M$828M$820M$764M
Gross profit$521M$513M$400M$313M$298M$285M$271M$257M$265M$267M$248M
Operating income$193M$194M$110M$53M$72M$79M$75M$69M$83M$99M$98M
Net income$103M$100M$48M$2M$33M$49M$54M$34M$55M$65M$65M
EPS (diluted)$2.51$2.43$1.19$0.06$0.81$1.21$1.34$0.83$0.00$0.00$0.00
R&D—$25M$24M$29M$24M$21M$18M$14M$12M$10M$9M
Revenue growth—+17.1%+27.4%+4.1%+3.8%+13.1%+4.1%−3.3%+1.0%+7.3%+1.7%

Cash flow

Fiscal yearTTM2026202520242023202220212020201920182017
Operating cash flow$86M$69M$80M$88M$13M$32M$48M$59M$47M$70M$98M
Capital spending-$64M-$59M-$38M-$41M-$52M-$37M-$29M-$34M-$30M-$19M-$21M
Free cash flow$22M$10M$42M$46M-$38M-$5M$19M$25M$17M$51M$78M
Dividends paid$19M$19M$19M$19M$19M$19M$19M$19M$19M$16M$16M
Buybacks———————————
Stock-based pay$2M$2M$717000$475000——$1M$2M$2M$334000$0

Balance sheet

Fiscal yearTTM2026202520242023202220212020201920182017
Cash—$82M$77M$115M$81M$91M$93M$91M$82M$79M$56M
Debt—$794M$768M$349M$369M$325M$341M$260M$231M$244M$250M
Equity—$385M$286M$257M$283M$262M$239M$188M$216M$185M$151M
Total assets—$1.5B$1.4B$982M$971M$932M$841M$784M$727M$672M$623M
Shares (diluted)41M41M41M41M41M41M41M41M41M40M40M

Margins and returns

Fiscal yearTTM2026202520242023202220212020201920182017
Gross margin33.8%33.8%30.9%30.8%30.5%30.3%32.6%32.1%32.0%32.6%32.5%
Operating margin12.5%12.8%8.5%5.2%7.3%8.4%9.0%8.6%10.1%12.1%12.8%
Net margin6.7%6.6%3.7%0.2%3.3%5.2%6.5%4.2%6.6%7.9%8.5%
FCF margin1.4%0.7%3.2%4.6%-3.9%-0.6%2.3%3.2%2.1%6.3%10.1%
ROIC—12.0%7.4%7.0%6.7%9.1%10.6%9.3%14.2%17.0%19.6%
ROE—25.9%16.9%0.9%11.5%18.7%22.8%17.8%25.3%35.1%42.8%

Frequently asked questions

What is Phibro Animal Health’s annual revenue?

$1.5B in fiscal 2026 and $1.5B over the twelve months to September 30, 2026.

How much profit does Phibro Animal Health make?

Net income was $100M in fiscal 2026 (net margin 6.6%).

Is Phibro Animal Health’s revenue growing?

Yes: revenue rose 17.1% in fiscal 2026 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.